Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain

Eva Martinez Moragon (Valencia, Spain), Eva Martínez Moragón, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Juan José Liñana Santafe, Marta Lleonart Dormuà

Source: International Congress 2015 – The immunology of allergic airway disease
Session: The immunology of allergic airway disease
Session type: Thematic Poster Session
Number: 2562
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eva Martinez Moragon (Valencia, Spain), Eva Martínez Moragón, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Juan José Liñana Santafe, Marta Lleonart Dormuà. Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain. Eur Respir J 2015; 46: Suppl. 59, 2562

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting
Source: International Congress 2017 – Asthma management
Year: 2017


Does having specialist asthma nurses improve adherence to national asthma guidelines? A comparison between two UK district general hospitals
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


How are we managing our asthmatic patients? Asthma diagnosis and treatment in an urban primary care practice
Source: Eur Respir J 2004; 24: Suppl. 48, 85s
Year: 2004

The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


The impact of telemedicine in healthcare demand by patients with severe persistent asthma
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016


Difference in healthcare resource use among children with asthma who did and did not have allergic rhinitis diagnosis in a UK primary care database
Source: Eur Respir J 2002; 20: Suppl. 38, 332s
Year: 2002

Cost of asthma in patients treated with national asthma guideline in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003

Assessment of the COPD patients’ care: An audit of clinical practice
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


The impact of a specialist multi-disciplinary approach to difficult asthma on healthcare outcomes in a district hospital
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013

The clinical and economic impact of the combined interventions of telehealth, specialist respiratory nursing care and health coaching interventions for COPD admissions within an urban setting
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Favorable results from a Dutch asthma/COPD service for primary care
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


Hospitalization rate as a measure of the outpatient management quality in children with asthma
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015


The contribution of an asthma diagnostic consultation service (ADCS) in obtaining an accurate asthma diagnosis for primary care patients
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


Treatment of asthma exacerbations managed in primary care in Spain
Source: Eur Respir J 2001; 18: Suppl. 33, 235s
Year: 2001

Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016


Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Economic implications of treatment pathways of asthma exacerbations managed in primary care in Spain
Source: Eur Respir J 2001; 18: Suppl. 33, 235s
Year: 2001

The effectiveness of patient education to improve adherence to the asthma treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016